(19)
(11) EP 1 185 514 A1

(12)

(43) Date of publication:
13.03.2002 Bulletin 2002/11

(21) Application number: 00938183.1

(22) Date of filing: 06.06.2000
(51) International Patent Classification (IPC)7: C07D 213/74, C07D 213/82, C07D 213/65, C07D 213/70, C07D 213/26, C07D 213/89, A61K 31/44, A61K 31/505
(86) International application number:
PCT/US0015/560
(87) International publication number:
WO 0075/110 (14.12.2000 Gazette 2000/50)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.06.1999 US 327141
07.06.1999 US 327774

(71) Applicant: Targacept, Inc.
Winston-Salem, NC 27102-1487 (US)

(72) Inventors:
  • DULL, Gary, Maurice
    Lewisville, NC 27023 (US)
  • MILLER, Craig, Harrison
    Winston-Salem, NC 27103 (US)
  • CALDWELL, William, Scott
    Winston-Salem, NC 27106 (US)
  • LYNM, Dwo
    Winston-Salem, NC 27103 (US)
  • BHATTI, Balwinder, Singh
    Winston-Salem, NC 27106 (US)
  • SCHMITT, Jeffrey, Daniel
    Winston-Salem, NC 27101 (US)
  • BYRD, Gary, Dwight
    Winston-Salem, NC 27127 (US)
  • HADIMANI, Srishailkumar, Basawannappa
    Winston-Salem, NC 27105 (US)

(74) Representative: Horner, Martin Grenville et al
Cruikshank & Fairweather19 Royal Exchange Square
Glasgow G1 3AEScotland
Glasgow G1 3AEScotland (GB)

   


(54) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE